MPG.eBooks - Search Results

Cover Image

1

Telehealth for patients with heart failure : a review of the clinical effectiveness, cost-effectiveness and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

2

Telehealth for patients with hypertension, coronary artery disease or implantable cardiac devices : a review of the clinical effectiveness, cost-effectiveness and guidelines

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

3

Boston keratoprosthesis for the treatment of corneal blindness : clinical effectiveness and cost-effectiveness

Published 2016

Canadian Agency for Drugs and Technologies in Health

Cover Image

4

Clinical review report: Rivaroxaban (Xarelto) Bayer Inc. : indication : in combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarctio...

Published 2019

CADTH

Cover Image

5

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Cover Image

6

Patient group input submissions: Ixekizumab (Taltz) for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or photothe...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

7

CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis

Published 2018

CADTH

Cover Image

8

Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents : a review of the effectiveness, safety, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

9

Pharmacoeconomic review report: Rivaroxaban (Xarelto) (Bayer Inc.) : indication : in combination with 75 mg to 100 mg acetylsalicylic acid (ASA), for the prevention of stroke, myoc...

Published 2019

CADTH

Cover Image

10

Viscoelastometric point-of-care testing for vascular surgery and obstetrics : a review of clinical utility and guidelines

Published 2016

CADTH Rapid Response Service

Cover Image

11

Metal versus acrylic partial removable dentures for patients with periodontal disease : a review of the clinical effectiveness and guidelines

Published 2016

CADTH Rapid Response Service

Cover Image

12

Metal versus plastic partial dentures for patients with periodontal disease : a review of the clinical effectiveness and safety

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

13

Excimer laser and stenting in patients with distal peripheral arterial disease : a review of the clinical effectiveness, safety, and guidelines

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

14

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

15

Patient group input submissions: Ivabradine (Lancora) for heart failure, NYHA class II to IV.

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

16

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Cover Image

17

Bioabsorbable stents for adults with coronary artery disease : a review of the clinical effectiveness, cost-effectiveness, and guidelines

Published 2013

Canadian Agency for Drugs and Technologies in Health

Cover Image

18

Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents : a review of the effectiveness, safety, and guidelines

Published 2014

Canadian Agency for Drugs and Technologies in Health

Cover Image

19

Patient group input submissions: AbobotulinumtoxinA (Dysport therapeutic) (Ipsen Biopharmaceuticals Canada, Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Cover Image

20

CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication : adult patients with active psoriatic arthritis (PsA) who have respon...

Published 2018

Canadian Agency for Drugs and Technologies in Health

1
2
3